BLES Biochemicals
Highly Engaged Employees
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
60 Pacific Crt 8, London, Ontario, N5V 3...Phone Number
(519) 457-2537Website
www.blesbiochem.comRevenue
<$5 MillionIndustry
About BLES Biochemicals
BLES Biochemicals Inc. is an established global player in providing innovative solutions for treating NRDS. With over 40 years of research and the development of BLES®, the leading pulmonary surfactant in Canada4, and now BLEScathTM , the company strives to provide interventions that expand the standard of care practices. The company's researchers aim to complement existing practices and enhance neonatal care to alleviate NRDS-related mortality and morbidity. Many premature infants with NRDS may not have survived without treatment with an exogenous pulmonary surfactant, such as BLES®. The company believes that everyone deserves access to this therapy, and the company works hard to make that a reality around the world. The innovation of BLEScathTM results from a continued commitment to that mission. The company want to live in a world where every neonate with NRDS has access to life-saving pulmonary surfactant and associated delivery devices. Until this vision is realized, the company cRead more
SIC Code 28,283NAICS Code 32,325Show moreBLES Biochemicals Org Chart
Compare Similar Companies to BLES Biochemicals
Compare insights from companies similar to BLES Biochemicals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BLES Biochemicals Tech Stack
A closer look at the technologies used by BLES Biochemicals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BLES Biochemicals
Sign Up For FreeTo access detailed company insights
BLES Biochemicals Inc. is an established global player in providing innovative solutions for treating NRDS. With over 40 years of research and the development of BLES®, the leading pulmonary surfactant in Canada4, and now BLEScathTM , the company strives to provide interventions that expand the standard of care practices. The company's researchers... Read More